Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Expert Reviews in Molecular Medicine

• Publication date

  2010-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1017/S1462399409001343PMID 20096141PMCID PMC2860793
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• APOBEC3 proteins mediate the clearance of foreign DNA from human cells

  2010cited by this paper
• The Range of Human APOBEC3H Sensitivity to Lentiviral Vif Proteins

  2009cited by this paper
• Differences in APOBEC3G Expression in CD4+ T Helper Lymphocyte Subtypes Modulate HIV-1 Infectivity

  2009cited by this paper
• APOBEC3G-Depleted Resting CD4+ T Cells Remain Refractory to HIV1 Infection

  2009cited by this paper
• Inhibition of HIV-1 Infection and Replication by Enhancing Viral Incorporation of Innate Anti-HIV-1 Protein A3G

  2009cited by this paper
• The current structural and functional understanding of APOBEC deaminases

  2009cited by this paper
• APOBEC3B deletion and risk of HIV-1 acquisition.

  2009cited by this paper
• HIV Evolution in Early Infection: Selection Pressures, Patterns of Insertion and Deletion, and the Impact of APOBEC

  2009cited by this paper
• Multiple ways of targeting APOBEC3-virion infectivity factor interactions for anti-HIV-1 drug development.

  2009cited by this paper
• Analysis of the Percentage of Human Immunodeficiency Virus Type 1 Sequences That Are Hypermutated and Markers of Disease Progression in a Longitudinal Cohort, Including One Individual with a Partially Defective Vif

  2009cited by this paper
• Accessories to the crime: Recent advances in HIV accessory protein biology

  2009cited by this paper
• Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance

  2009cited by this paper
• Identification of a Novel WxSLVK Motif in the N Terminus of Human Immunodeficiency Virus and Simian Immunodeficiency Virus Vif That Is Critical for APOBEC3G and APOBEC3F Neutralization

  2009influential reference
• Sole copy of Z2‐type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV‐1.

  2009cited by this paper
• Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent.

  2009cited by this paper
• An extended structure of the APOBEC3G catalytic domain suggests a unique holoenzyme model.

  2009cited by this paper
• Microarray Analysis of Lymphatic Tissue Reveals Stage-Specific, Gene Expression Signatures in HIV-1 Infection1

  2009influential reference
• APOBEC3G mRNA expression in exposed seronegative and early stage HIV infected individuals decreases with removal of exposure and with disease progression

  2009cited by this paper
• Architecture and Secondary Structure of an Entire HIV-1 RNA Genome

  2009cited by this paper
• Tumultuous Relationship between the Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) and the Human APOBEC-3G and APOBEC-3F Restriction Factors

  2009cited by this paper
• Reassessing the Role of APOBEC3G in Human Immunodeficiency Virus Type 1 Infection of Quiescent CD4+ T-Cells

  2009cited by this paper
• RNA-Dependent Oligomerization of APOBEC3G Is Required for Restriction of HIV-1

  2009cited by this paper
• Structure, interaction and real‐time monitoring of the enzymatic reaction of wild‐type APOBEC3G

  2009cited by this paper
• A Patch of Positively Charged Amino Acids Surrounding the Human Immunodeficiency Virus Type 1 Vif SLVx4Yx9Y Motif Influences Its Interaction with APOBEC3G

  2009cited by this paper
• Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

  2009cited by this paper
• APOBEC proteins and intrinsic resistance to HIV-1 infection

  2009influential reference
• Defining APOBEC3 Expression Patterns in Human Tissues and Hematopoietic Cell Subsets

  2009cited by this paper
• Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells.

  2009cited by this paper
• Retrovirology BioMed Central Review HIV-1 Vif, APOBEC, and Intrinsic Immunity

  2008cited by this paper
• Hepatitis B: modern concepts in pathogenesis – APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus

  2008cited by this paper
• APOBEC3G-UBA2 fusion as a potential strategy for stable expression of APOBEC3G and inhibition of HIV-1 replication

  2008cited by this paper
• Polymorphisms and Splice Variants Influence the Antiretroviral Activity of Human APOBEC3H

  2008cited by this paper
• Distinct Determinants in HIV-1 Vif and Human APOBEC3 Proteins Are Required for the Suppression of Diverse Host Anti-Viral Proteins

  2008cited by this paper
• The APOBEC3 cytidine deaminases: an innate defensive network opposing exogenous retroviruses and endogenous retroelements.

  2008cited by this paper
• APOBEC3G and APOBEC3F Require an Endogenous Cofactor to Block HIV-1 Replication

  2008cited by this paper
• Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G.

  2008cited by this paper
• Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.

  2008cited by this paper
• Small-molecule inhibition of HIV-1 Vif

  2008cited by this paper
• Function analysis of sequences in human APOBEC3G involved in Vif-mediated degradation.

  2008cited by this paper
• Functional domain organization of human APOBEC3G.

  2008cited by this paper
• Vpr.A3A Chimera Inhibits HIV Replication*

  2008cited by this paper
• Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G

  2008cited by this paper
• Regulation of APOBEC3 Proteins by a Novel YXXL Motif in Human Immunodeficiency Virus Type 1 Vif and Simian Immunodeficiency Virus SIVagm Vif

  2008cited by this paper
• Human Cytidine Deaminase APOBEC3H Restricts HIV-1 Replication*

  2008cited by this paper
• Antiretroelement activity of APOBEC3H was lost twice in recent human evolution.

  2008cited by this paper
• Vpr14-88-Apobec3G Fusion Protein Is Efficiently Incorporated into Vif-Positive HIV-1 Particles and Inhibits Viral Infection

  2008cited by this paper
• Equine Infectious Anemia Virus Resists the Antiretroviral Activity of Equine APOBEC3 Proteins through a Packaging-Independent Mechanism

  2008cited by this paper
• Human Immunodeficiency Virus (HIV) Type 1 Proviral Hypermutation Correlates with CD4 Count in HIV-Infected Women from Kenya

  2008cited by this paper
• APOBEC3G Inhibits Elongation of HIV-1 Reverse Transcripts

  2008cited by this paper
• Identification of amino acid residues in HIV-1 Vif critical for binding and exclusion of APOBEC3G/F.

  2008cited by this paper
• Relationship between human immunodeficiency type 1 infection and expression of human APOBEC3G and APOBEC3F.

  2008cited by this paper
• The DNA Deaminase Activity of Human APOBEC3G Is Required for Ty1, MusD, and Human Immunodeficiency Virus Type 1 Restriction

  2008cited by this paper
• Distinct Domains within APOBEC3G and APOBEC3F Interact with Separate Regions of Human Immunodeficiency Virus Type 1 Vif

  2008cited by this paper
• The Level of APOBEC3G (hA3G)-Related G-to-A Mutations Does Not Correlate with Viral Load in HIV Type 1-Infected Individuals

  2008cited by this paper
• Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications

  2008cited by this paper
• HIV-1 accessory proteins--ensuring viral survival in a hostile environment.

  2008cited by this paper
• Cytidine deamination induced HIV-1 drug resistance

  2008cited by this paper
• Human Immunodeficiency Virus Type 1 Vif Functionally Interacts with Diverse APOBEC3 Cytidine Deaminases and Moves with Them between Cytoplasmic Sites of mRNA Metabolism

  2007cited by this paper
• Cytidine Deaminases APOBEC3G and APOBEC3F Interact with Human Immunodeficiency Virus Type 1 Integrase and Inhibit Proviral DNA Formation

  2007cited by this paper
• APOBEC3G Inhibits DNA Strand Transfer during HIV-1 Reverse Transcription*

  2007cited by this paper
• The APOBEC-2 crystal structure and functional implications for the deaminase AID

  2007cited by this paper
• Identification of Two Distinct Human Immunodeficiency Virus Type 1 Vif Determinants Critical for Interactions with Human APOBEC3G and APOBEC3F

  2007cited by this paper
• Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G

  2007cited by this paper
• Enzymatically Active APOBEC3G Is Required for Efficient Inhibition of Human Immunodeficiency Virus Type 1

  2007influential reference
• Retrovirology BioMed Central Commentary Turning up the volume on mutational pressure: Is more of a good

  2007cited by this paper
• Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression.

  2007influential reference
• Human Immunodeficiency Virus Type 1 cDNAs Produced in the Presence of APOBEC3G Exhibit Defects in Plus-Strand DNA Transfer and Integration

  2007cited by this paper
• Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity

  2007cited by this paper
• Apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G: a possible role in the resistance to HIV of HIV-exposed seronegative individuals.

  2007cited by this paper
• APOBEC3F Can Inhibit the Accumulation of HIV-1 Reverse Transcription Products in the Absence of Hypermutation

  2007cited by this paper
• Genetic therapies against HIV

  2007cited by this paper
• Identification of Amino Acid Residues in APOBEC3G Required for Regulation by Human Immunodeficiency Virus Type 1 Vif and Virion Encapsidation

  2007cited by this paper
• The intrinsic antiretroviral factor APOBEC3B contains two enzymatically active cytidine deaminase domains.

  2007cited by this paper
• APOBEC-mediated viral restriction: not simply editing?

  2007cited by this paper
• Inhibition of initiation of reverse transcription in HIV-1 by human APOBEC3F.

  2007cited by this paper
• Role of APOBEC3G/F-Mediated Hypermutation in the Control of Human Immunodeficiency Virus Type 1 in Elite Suppressors

  2007cited by this paper
• Virion-associated Uracil DNA Glycosylase-2 and Apurinic/Apyrimidinic Endonuclease Are Involved in the Degradation of APOBEC3G-edited Nascent HIV-1 DNA*

  2007cited by this paper
• Population Stratification of a Common APOBEC Gene Deletion Polymorphism

  2007cited by this paper
• All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition

  2007cited by this paper
• Antiviral Potency of APOBEC Proteins Does Not Correlate with Cytidine Deamination

  2006cited by this paper
• APOBEC3 Proteins Inhibit Human LINE-1 Retrotransposition*

  2006cited by this paper
• APOBEC3B and APOBEC3F Inhibit L1 Retrotransposition by a DNA Deamination-independent Mechanism*

  2006cited by this paper
• Alpha Interferon Potently Enhances the Anti-Human Immunodeficiency Virus Type 1 Activity of APOBEC3G in Resting Primary CD4 T Cells

  2006cited by this paper
• Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti–HIV-1 activity

  2006cited by this paper
• Cellular inhibitors of long interspersed element 1 and Alu retrotransposition.

  2006cited by this paper
• APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians

  2006cited by this paper
• Reversed Functional Organization of Mouse and Human APOBEC3 Cytidine Deaminase Domains*

  2006cited by this paper
• Population Level Analysis of Human Immunodeficiency Virus Type 1 Hypermutation and Its Relationship with APOBEC3G and vif Genetic Variation

  2006cited by this paper
• APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells

  2006cited by this paper
• Uracil DNA Glycosylase Is Dispensable for Human Immunodeficiency Virus Type 1 Replication and Does Not Contribute to the Antiviral Effects of the Cytidine Deaminase Apobec3G

  2006cited by this paper
• Adaptive Evolution and Antiviral Activity of the Conserved Mammalian Cytidine Deaminase APOBEC3H

  2006cited by this paper
• Inhibition of \batchmode \documentclass[fleqn,10pt,legalpaper]{article} \usepackage{amssymb} \usepackage{amsfonts} \usepackage{amsmath} \pagestyle{empty} \begin{document} \(\mathrm{tRNA}_{3}^{\mathrm{Lys}}\) \end{document}-Primed Reverse Transcription by Human APOBEC3G during Human Immunodeficiency

  2006cited by this paper
• APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons.

  2006cited by this paper
• Human APOBEC3 proteins, retrovirus restriction, and HIV drug resistance.

  2006cited by this paper
• APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection

  2006cited by this paper
• Differential Requirement for Conserved Tryptophans in Human Immunodeficiency Virus Type 1 Vif for the Selective Suppression of APOBEC3G and APOBEC3F

  2006cited by this paper
• Identification of APOBEC3DE as Another Antiretroviral Factor from the Human APOBEC Family

  2006cited by this paper
• APOBEC3F and APOBEC3G mRNA Levels Do Not Correlate with Human Immunodeficiency Virus Type 1 Plasma Viremia or CD4+ T-Cell Count

  2006cited by this paper
• Exhaustive genotyping of the CEM15 (APOBEC3G) gene and absence of association with AIDS progression in a French cohort.

  2005cited by this paper
• Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells

  2005cited by this paper

• The emerging roles of ubiquitin-like modifications in regulating HIV replication and host defense

  2025cites this paper
• The Use of Nonhuman Primate Models for Advancing HIV PrEP

  2025cites this paper
• The Intricate Interplay between APOBEC3 Proteins and DNA Tumour Viruses

  2024cites this paper
• Archived HIV-1 Drug Resistance Mutations: Role of Proviral HIV-1 DNA Genotype for the Management of Virological Responder People Living with HIV

  2024cites this paper
• Host ZCCHC3 blocks HIV-1 infection and production through a dual mechanism

  2024cites this paper
• Structural basis for recruitment of host CypA and E3 ubiquitin ligase by maedi-visna virus Vif

  2023cites this paper
• Host ZCCHC3 blocks HIV-1 infection and production by a dual mechanism

  2023cites this paper
• Army liposome formulation containing QS-21 render human monocyte-derived macrophages less permissive to HIV-1 infection by upregulating APOBEC3A

  2022cites this paper
• Partitioning of ribonucleoprotein complexes from the cellular actin cortex

  2021cites this paper
• Structure-Based Design of First-Generation Small Molecule Inhibitors Targeting the Catalytic Pockets of AID, APOBEC3A, and APOBEC3B

  2021cites this paper
• Upregulation of the APOBEC3 Family Is Associated with a Poor Prognosis and Influences Treatment Response to Raf Inhibitors in Low Grade Glioma

  2021cites this paper
• Comprehensive Investigation on the Interplay between Feline APOBEC3Z3 Proteins and Feline Immunodeficiency Virus Vif Proteins

  2021cites this paper
• The Role of APOBECs in Viral Replication

  2020cites this paper
• Interruption of Vif/Elongin C interaction: In silico and experimental elucidation of the underlying molecular mechanism of benzimidazole-based APOBEC3G stabilizers.

  2020cites this paper
• Maedi–visna virus Vif protein uses motifs distinct from HIV-1 Vif to bind zinc and the cofactor required for A3 degradation

  2020influential citation
• Mycobacterium tuberculosis Reactivates HIV-1 via Exosome-Mediated Resetting of Cellular Redox Potential and Bioenergetics

  2020cites this paper
• Maedi-visna virus Vif protein uses motifs distinct from HIV-1 Vif to bind zinc and cofactor required for A3 degradation.

  2020cites this paper
• The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead

  2020cites this paper
• Inhibition of Vif-Mediated Degradation of APOBEC3G through Competitive Binding of Core-Binding Factor Beta

  2020cites this paper
• Impact of Suboptimal APOBEC3G Neutralization on the Emergence of HIV Drug Resistance in Humanized Mice

  2019cites this paper
• APOBEC3G is a restriction factor of EV71 and mediator of IMB‐Z antiviral activity

  2019cites this paper
• APOBEC3G Regulation of the Evolutionary Race Between Adaptive Immunity and Viral Immune Escape Is Deeply Imprinted in the HIV Genome

  2019cites this paper
• Synergistic Lethal Mutagenesis of Hepatitis C Virus

  2019cites this paper
• Abstract. Human T-cell leukemia virus type 1 (HTLV-1) is the causative agent of adult T-cell leukemia/lymphoma (ATL). Following viral infection with HTLV-1, certain infected cells exhibit clonal proliferation. Additional genetic and epigenetic changes in these clonally proliferating cells provide th

  2019cites this paper
• Reconsidering the Model of Trim5α Assembly: The Role of the Linker2 (l2) Region in Trim5α Assembly

  2019cites this paper
• Mycobacterium tuberculosis reactivates HIV via exosomes mediated resetting of cellular redox potential and bioenergetics

  2019cites this paper
• An Alu Element Insertion in Intron 1 Results in Aberrant Alternative Splicing of APOBEC3G Pre-mRNA in Northern Pig-Tailed Macaques (Macaca leonina) That May Reduce APOBEC3G-Mediated Hypermutation Pressure on HIV-1

  2019cites this paper
• Role of co-expressed APOBEC3F and APOBEC3G in inducing HIV-1 drug resistance

  2019cites this paper
• Induction of APOBEC3B cytidine deaminase in HTLV-1-infected humanized mice.

  2019cites this paper
• G protein-coupled and ATP-sensitive inwardly rectifying potassium ion channels are essential for HIV entry

  2019cites this paper
• RETRACTED ARTICLE: Dramatic HIV DNA degradation associated with spontaneous HIV suppression and disease-free outcome in a young seropositive woman following her infection

  2019cites this paper
• Impact des inhibiteurs de l'intégrase sur la constitution et la compartimentalisation du réservoir viral

  2018cites this paper
• Biochemical Basis of APOBEC3 Deoxycytidine Deaminase Activity on Diverse DNA Substrates.

  2018cites this paper
• Host Restriction Factors APOBEC3G/3F and Other Interferon-Related Gene Expressions Affect Early HIV-1 Infection in Northern Pig-Tailed Macaque (Macaca leonina)

  2018cites this paper
• Viral subversion of APOBEC3s: Lessons for anti-tumor immunity and tumor immunotherapy

  2018cites this paper
• A comprehensive study on cellular RNA editing activity in response to infections with different subtypes of influenza a viruses

  2018cites this paper
• Human interleukin‐34‐derived macrophages have increased resistance to HIV‐1 infection

  2018cites this paper
• APOBEC3G/3A Expression in Human Immunodeficiency Virus Type 1-Infected Individuals Following Initiation of Antiretroviral Therapy Containing Cenicriviroc or Efavirenz

  2018cites this paper
• Multiple Inhibitory Factors Act in the Late Phase of HIV-1 Replication: a Systematic Review of the Literature

  2018cites this paper
• APOBEC3H Subcellular Localization Determinants Define Zipcode for Targeting HIV-1 for Restriction

  2018cites this paper
• CHARACTERIZATION OF APOBEC3 REPERTOIRES AND EFFECTS ON RETROVIRAL REPLICATION

  2018cites this paper
• STUDIES ON THE MECHANISMS OF ANTI-HIV-1 FUNCTIONS OF APOBEC3F AND APOBEC3G

  2017influential citation
• Enhancing the Catalytic Deamination Activity of APOBEC3C Is Insufficient to Inhibit Vif-Deficient HIV-1.

  2017cites this paper
• Syphilis Infection Differentially Regulates the Phenotype and Function of γδ T Cells in HIV-1-Infected Patients Depends on the HIV-1 Disease Stage

  2017cites this paper
• Interleukin 32: a novel player in the control of infectious diseases

  2017cites this paper
• APOBEC Enzymes as Targets for Virus and Cancer Therapy.

  2017cites this paper
• Title ASK 1 restores the antiviral activity of APOBEC 3 G bydisrupting HIV-1 Vif-mediated counteraction

  2017cites this paper
• A conflict of interest: the evolutionary arms race between mammalian APOBEC3 and lentiviral Vif

  2017cites this paper
• Mutation Processes in 293-Based Clones Overexpressing the DNA Cytosine Deaminase APOBEC3B

  2016cites this paper
• Species‐specific differences in the ability of feline lentiviral Vif to degrade feline APOBEC3 proteins

  2016cites this paper
• Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation*

  2016cites this paper
• APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication

  2016cites this paper
• The Structural Interface between HIV-1 Vif and Human APOBEC3H

  2016cites this paper
• Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G

  2016influential citation
• Inhibition of APOBEC3G activity impedes double‐stranded DNA repair

  2016cites this paper
• Error-prone DNA polymerase and oxidative stress increase the incidences of A to G mutations in tumors

  2016cites this paper
• Increased expression with differential subcellular location of cytidine deaminase APOBEC3G in human CD4+ T‐cell activation and dendritic cell maturation

  2016cites this paper
• Role of APOBEC3F Gene Variation in HIV-1 Disease Progression and Pneumocystis Pneumonia

  2016cites this paper
• HIV Genome-Wide Protein Associations: a Review of 30 Years of Research

  2016cites this paper
• Reconsidering the Model of Trim 5 α Assembly : The Role of the Linker 2 ( l 2 ) Region in Trim 5 α Assembly

  2015cites this paper
• APOBEC3G genotypes and proviral DNA hypermutations on HIV/AIDS disease progression in Thai and Cambodian children

  2015cites this paper
• Vif determines the requirement for CBF-β in APOBEC3 degradation.

  2015cites this paper
• Impacts of Humanized Mouse Models on the Investigation of HIV-1 Infection: Illuminating the Roles of Viral Accessory Proteins in Vivo

  2015cites this paper
• Natural Polymorphisms and Oligomerization of Human APOBEC3H Contribute to Single-stranded DNA Scanning Ability*

  2015cites this paper
• Structural Insights into HIV-1 Vif-APOBEC3F Interaction

  2015cites this paper
• HIV-1 and interferons: who's interfering with whom?

  2015cites this paper
• Oxidative Reactivities of 2-Furylquinolines: Ubiquitous Scaffolds in Common High-Throughput Screening Libraries.

  2015cites this paper
• ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction

  2015cites this paper
• Suppression of APOBEC3-mediated restriction of HIV-1 by Vif

  2014cites this paper
• Different Mutagenic Potential of HIV-1 Restriction Factors APOBEC3G and APOBEC3F Is Determined by Distinct Single-Stranded DNA Scanning Mechanisms

  2014cites this paper
• Lack of Association between Intact/Deletion Polymorphisms of the APOBEC3B Gene and HIV-1 Risk

  2014cites this paper
• Contribution of APOBEC3-Driven Mutagenesis to HIV Evolution and HIV Drug Resistance

  2014cites this paper
• APOBEC3-mediated hypermutation of retroviruses:A defensive tool of the innate immune system

  2014cites this paper
• Small molecules that inhibit Vif-induced degradation of APOBEC3G

  2014cites this paper
• Requirement of HIV-1 Vif C-terminus for Vif-CBF-β interaction and assembly of CUL5-containing E3 ligase

  2014cites this paper
• A computational analysis of the structural determinants of APOBEC3's catalytic activity and vulnerability to HIV-1 Vif.

  2014cites this paper
• Reconsidering the model of TRIM5alpha assembly: The role of the Linker2 (l2) region in TRIM5alpha assembly

  2014cites this paper
• Mouse knockout models for HIV-1 restriction factors

  2014cites this paper
• Problems and Prospects of Gene Therapy Against HIV

  2014cites this paper
• Replication potentials of HIV-1/HSIV in PBMCs from northern pig-tailed macaque (Macaca leonina).

  2014cites this paper
• CBF (cid:2) Enhances De Novo Protein Biosynthesis of Its Binding Partners HIV-1 Vif and RUNX1 and Potentiates the Vif-Induced Degradation of APOBEC3G

  2014cites this paper
• Pathogens

  2014cites this paper
• Natural Polymorphisms in Human APOBEC3H and HIV-1 Vif Combine in Primary T Lymphocytes to Affect Viral G-to-A Mutation Levels and Infectivity

  2014cites this paper
• APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element.

  2014cites this paper
• Quantification of Deaminase Activity-Dependent and -Independent Restriction of HIV-1 Replication Mediated by APOBEC3F and APOBEC3G through Experimental-Mathematical Investigation

  2014influential citation
• DIFFERENTIAL EFFECTS OF MOUSE APOBEC3 AFTER INCORPORATION INTO MURINE LEUKEMIA VIRUSES

  2014influential citation
• APOBEC3 multimerization correlates with HIV-1 packaging and restriction activity in living cells.

  2014cites this paper
• CBFβ Enhances De Novo Protein Biosynthesis of Its Binding Partners HIV-1 Vif and RUNX1 and Potentiates the Vif-Induced Degradation of APOBEC3G

  2014cites this paper
• USE OF GENE THERAPY TO CURE AIDS

  2014cites this paper
• Catalytic activity of APOBEC3F is required for efficient restriction of Vif-deficient human immunodeficiency virus.

  2014cites this paper
• AID and APOBECs span the gap between innate and adaptive immunity

  2014influential citation
• Interleukin-32 isoforms: expression, interaction with interferon-regulated genes and clinical significance in chronically HIV-1-infected patients

  2014cites this paper
• Evaluation of Anti-HIV-1 Mutagenic Nucleoside Analogues*

  2014cites this paper
• Spread to CD 4 Immature Dendritic Cells and Limits HIV-1 Induces APOBEC 3 G , F , and A in α

  2013cites this paper
• The ancient and recurrent evolution of Apobec3 antiviral activity in primates

  2013cites this paper
• Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1

  2013cites this paper
• BIOCHEMICAL ANALYSIS OF HIV RESTRICTION FACTORS: SINGLE DOMAIN DEOXYCYTIDINE DEAMINASES APOBEC3A AND APOBEC3H

  2013influential citation
• Insight into the HIV-1 Vif SOCS-box–ElonginBC interaction

  2013cites this paper
• Combinatorial RNA-based gene therapy for the treatment of HIV/AIDS

  2013cites this paper
• The Resistance of Human APOBEC3H to HIV-1 NL4-3 Molecular Clone Is Determined by a Single Amino Acid in Vif

  2013cites this paper